Florida Cancer Specialists’ Physicians & Executives Provide Leadership for National Community Oncology Conference
- Amanda Bridges
- May 2, 2017
- News
Brought to you by a 100% FLASCO member partner
Physicians, Administrators, Nurses, Pharmacists and Patient Advocates
Share Latest Innovations in Cancer Care
Washington, D.C. – May 1, 2017……… The 2017 Community Oncology Conference, which was convened April 27 – 28, 2017 in Washington, D.C., drew over 1300 oncologists, administrators, nurses, pharmacists, industry leaders and patient advocates to the nation’s capital to discuss some of the most recent advancements in cancer care today. Hosted by the Community Oncology Alliance (COA), this year’s conference featured numerous physicians and leaders from Florida Cancer Specialists & Research Institute (FCS), including Dr. Michael Diaz, Dr. Craig Reynolds, FCS Founder and President Dr. William Harwin, Dr. Lucio Gordan, who served as a national co-chair for the conference, FCS Director of Pharmacy Ray Bailey and FCS CEO Brad Prechtl. Sitting on panels post conference were Don Champlain, Associate Director of Care Management and Sarah Cevallos, Chief Revenue Cycle Officer.
FCS CEO Brad Prechtl, who participated in a panel discussion on the Practice Vision for the Now & Future of Community Oncology, said, “As one of the practices selected to participate in the Oncology Care Model, FCS has been at the cutting-edge of developing new strategies, as we transition to a value-based care model. Sharing experiences with other community oncologists and administrators strengthens our ability to deliver innovative new therapies and services to our patients.”
Dr. William Harwin, Founder and President of FCS, addressed the conference during a panel discussion on How Community Oncology Is Fueling the Cancer Moonshot. “Our capacity to share big data and information from clinical research is greatly improving our understanding of cancer and our ability to treat it,” said Dr. Harwin. “This data is guiding physicians in tailoring and personalizing treatment strategies to each patient’s unique genetic makeup for maximum effectiveness.”
Conference co-chair Dr. Lucio Gordan, who practices at the Gainesville Cancer Center, added, “Community oncology practices have truly taken the lead in delivering cutting-edge treatments, driving clinical research and developing innovative payment and delivery system reforms. As front-line providers of cancer care, community oncology practices understand the challenges of our current cancer care system and are dedicated to improving treatments and providing cost-effective, patient-centric solutions.”
Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.
###
About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 160 nurse practitioners and physician assistants and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 84% of new cancer drugs approved in 2016 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state’s leading hospitals.
FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities and on the East Coast from Palm Beach County to Daytona/Palm Coast.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
* Prior to approval
For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer – sglenn@flcancer.com
770.365.6168
ChappellRoberts
Chris Wilkerson – cwilkerson@chappellroberts.com
813.857.7051
Ganick Communications, Inc.
Elaine Ganick – elaine@ganick.com
615.377.7877
